IMMUNOGLOBULIN A NEPHROPATHY
Clinical trials for IMMUNOGLOBULIN A NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new IMMUNOGLOBULIN A NEPHROPATHY trials appear
Sign up with your email to follow new studies for IMMUNOGLOBULIN A NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kidney disease: ravulizumab trial targets protein leak
Disease control Recruiting nowThis phase 3 study tests whether ravulizumab can reduce protein in urine and slow kidney function decline in adults with IgA nephropathy, a disease that can lead to kidney failure. About 510 participants will receive either the drug or a placebo. The goal is to see if the drug he…
Matched conditions: IMMUNOGLOBULIN A NEPHROPATHY
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New hope for kids with rare kidney diseases: sparsentan trial launches
Disease control Recruiting nowThis study is testing a drug called sparsentan in children with certain kidney diseases that cause protein leakage in urine. The goal is to see if the drug can safely reduce protein levels and help protect kidney function over about two years. Around 67 children will take the med…
Matched conditions: IMMUNOGLOBULIN A NEPHROPATHY
Phase: PHASE2 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC